Cancel
Katharine Peterson
Finance & Accounting
@
Acrivon Therapeutics
jz626b555@u3d5gl8.qqq
Sign up to see email
Known information
- Holds an MS in Accountancy from the University of Notre Dame.
- Extensive experience in public accounting and biotech companies across both finance and accounting roles.
- Expertise includes financial management and reporting, operational efficiencies, system rollouts, and strategic and operational planning to support high-growth life science companies.
- Previously held positions at Wave Life Sciences, Spero Therapeutics, and Merrimack Pharmaceuticals.
- Began career in the life sciences assurance practice at EY.
- Helped multiple small biotech companies with public company readiness and IPO-directed efforts.
- Over a decade of experience in the biotechnology industry.
- Worked on financial management, operations, technical accounting, reporting, and planning.
- Senior Director of Financial Planning & Analysis at Wave Life Sciences.
- Held various roles within both Spero Therapeutics and Merrimack Pharmaceuticals.
- Holds a BA in Business Economics from Providence College.
- Certified Public Accountant (CPA) in the state of Massachusetts.
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information
